(Q45800065)

16 December 2017

title

Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous intravenous infusion (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

16 September 2023

1 reference

S. A. Spector

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285719

16 September 2023

M. Hintz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285719

16 September 2023

C. Wyborny

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285719

16 September 2023

J. D. Connor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285719

16 September 2023

R. E. Keeney

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285719

16 September 2023

S. Liao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285719

16 September 2023

language of work or name

English

0 references

publication date

1 July 1982

1 reference

16 December 2017

20 July 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6285719

full work available at URL

16 September 2023

https://api.elsevier.com/content/article/PII:000293438290105X?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

https://api.elsevier.com/content/article/PII:000293438290105X?httpAccept=text/plain

16 September 2023

1 reference

Crossref

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

American Journal of Medicine

16 September 2023

published in

1 reference

16 December 2017

volume

1 reference

16 December 2017

issue

1 reference

16 December 2017

page(s)

275-280

1 reference

16 December 2017

9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group

cites work

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

Drug therapy: antiviral agents (second of two parts).

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

Parenteral acyclovir therapy for herpesvirus infections in man

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

Acyclovir prophylaxis of herpes-simplex-virus infections

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

Acyclovir kinetics after intravenous infusion

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

Single-dose pharmacokinetics of acyclovir

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

Adenine Arabinoside for Therapy of Herpes Zoster in Immunosuppressed Patients: Preliminary Results of a Collaborative Study

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

Pharmacology, Tolerance, and Antiviral Activity of Vidarabine Monophosphate in Humans

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90105-X

16 September 2023

Identifiers

1 reference

16 December 2017

1 reference

16 December 2017